Amcor: The Market Is Still Mispricing This High-Yield Dividend Aristocrat

Amcor was reaffirmed as a Strong Buy after Q3 FY26 results beat expectations, with 6% adjusted EPS growth and a 15.1% adjusted EBITDA margin. Management raised/confirmed guidance for $1.5-$1.6 billion in free cash flow and 12% adjusted EPS growth, supported by $270 million in Berry synergies and up to $2.5 billion in divestiture proceeds. The stock also offers an attractive ~6.9% dividend yield and remains viewed as undervalued despite a recent share price jump.

Analysis

AMCR is increasingly looking like a balance-sheet monetization story disguised as a defensive compounder. The market is still valuing it as a low-growth packaging name, but the combination of portfolio simplification, divestiture proceeds, and synergy capture creates a cleaner capital-allocation runway that should compress the discount to peers over the next 2-4 quarters. The key second-order effect is that deleveraging plus a large yield changes the shareholder base: income funds can step in, which tends to support the stock on pullbacks and lowers volatility.

The more interesting setup is that the upside may come less from the core business than from capital structure optionality. If proceeds are redirected to debt reduction, buybacks, or a mix, incremental equity value can compound faster than headline EBITDA growth suggests, especially if the market begins to underwrite a more normal multiple once execution risk falls. That said, the sustainability of the thesis depends on whether the synergy and divestiture benefits arrive before macro cost pressure or integration friction offsets them.

BRY is a separate and more fragile leg of the story: the market appears to be treating the transaction-related benefit as real while discounting ongoing execution and asset-quality risk. If packaging customers or creditors start to question integration or working-capital discipline, the implied synergy value can get repriced quickly. The main contrarian point is that a high yield plus strong guidance can still be a value trap if the market concludes free cash flow is being boosted by temporary working-capital release rather than durable operating conversion.

Key Decisions for Investors

• Long AMCR outright for 3-6 months into the next earnings cycle; target a re-rating toward peer packaging multiples as deleveraging and portfolio simplification become more visible.
• Sell downside on AMCR via put spreads 8-12% below spot for the next 1-2 quarters; the yield and expected cash generation should provide a meaningful floor unless macro weakens sharply.
• Pair long AMCR / short a lower-quality packaging or levered materials peer for 1-2 quarters; express the view that AMCR’s cleaner capital allocation will outperform higher-beta balance-sheet stories.
• Avoid chasing BRY as a standalone long until there is clearer evidence that synergy capture is translating into durable free cash flow; use it only as a tactical event-driven trade, not a core hold.